宁泌泰胶囊联合UPOINT临床分型系统个性化治疗湿热下注型慢性前列腺炎临床观察
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R697+.33

基金项目:


Clinical Observation on Ningbitai Capsu les Com bined with Ind ividualized Treatment of UPOINT Clinical Classification System for Ch ronic Prostatitis of Damp-heat Flow ing Dow nw ard Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察宁泌泰胶囊联合慢性前列腺炎临床分型系统(UPOINT)个性化治疗湿热下注型慢性前列腺炎的临床疗效。方法:将103例湿热下注型慢性前列腺炎患者随机分为2组,观察组52例采用宁泌泰胶囊+UPOINT个性化综合治疗;对照组51例单纯采用宁泌泰胶囊治疗;疗程均为8周,观察比较2组治疗前后传统慢性前列腺炎症状评分(NIH-CPSI)和中医证候评分变化,评价临床治疗效果。结果:治疗后,总有效率观察组为94.23%,对照组为78.43%,2组比较,差异有统计学意义( P <0.05)。治疗后,2组NIH-CPSI评分、中医证候评分均较治疗前降低( P <0.05);且观察组上述评分下降较对照组更显著( P <0.05)。结论:在宁泌泰胶囊治疗的基础上,根据UPOINT临床分型系统对慢性前列腺炎患者进行个性化治疗可以显著提高临床疗效。

    Abstract:

    Objective:To observe the clinical effect of Ningbitai capsules com bined with the individualized treatment of UPOINT clinical classification system for chronic prostatitis of damp-heat flow ing dow nw ard type.Methods:Divided 103 cases of patients with chronic prostatitis of damp-heat flow ing dow nw ard type randomly into the observation group and the control group,52 and 51 cases in each group respectively.The observation group was treated with Ningbitai capsules com bined with UPOINT comprehensive individualized treatment,while the control group was simply given Ningbitai capsules for treatment.The treatment of the two groups lasted for eight weeks.Before and after treatment,compared the changes in scores of the National Institutes of Health-Chronic Prostatitis Symptom Index(NIH-CPSI)and scores of Chinese medicine syndrome,and evaluated the clinicaleffect of the two groups.Results:After treatment,the totaleffective rate was 94.23%in the observation group and 78.43%in the control group,the difference being significant( P <0.05).After treatment,scores of NIH-CPSI and of Chinese medicine syndrome in the two groups were decreased when compared with those before treatment( P <0.05);the above scores in the observation group were decreased more significantly than those in the control group( P <0.05).Conclusion:Based on the treatment of Ningbitai capsules,the additional use of individualized treatment of UPOINT clinical classification system can significantly improve the clinicaleffect in treating patients with chronic prostatitis.

    参考文献
    相似文献
    引证文献
引用本文

尚亚峰,张艺,康延杰,孙建涛,韩兴涛.宁泌泰胶囊联合UPOINT临床分型系统个性化治疗湿热下注型慢性前列腺炎临床观察[J].新中医,2018,50(9):147-149

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-09-04
  • 出版日期: